Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +739.75%
#3 ADO Protocol ADO Protocol +101.64%
#4 Cortex Cortex +93.46%
#5 Ontology Gas Ontology Gas +76.57%
#6 Kinesis Silver Kinesis Silver +52.82%
#7 OpenEden OpenEden +38.13%
#8 Magma Finance Magma Finance +32.63%
#9 Biconomy Biconomy +23.61%
#10 QuantixAI QuantixAI +23.21%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Medigen Biotechnology Corp. Medigen Biotechnology Corp.

Medigen Biotechnology Corp.

3176
Clasificación en acciones #19054
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated... Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
Precio por acción
$1.27
Capitalización bursátil
$176.31M
Cambio (1 día)
5.57%
Cambio (1 año)
29.36%
País
TW
Comercio Medigen Biotechnology Corp. (3176)

Categoría

Healthcare
Ratio P/B de Medigen Biotechnology Corp. (3176)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Medigen Biotechnology Corp., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Medigen Biotechnology Corp. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH